Lensar (LNSR) Non-Current Receivables (2019 - 2026)
Lensar (LNSR) reported Non-Current Receivables of $658000.0 for Q1 2026, down 29.78% year-over-year from $937000.0 in Q1 2025, and down 9.99% on a QoQ basis from $731000.0 in Q4 2025.
Lensar (LNSR) has 8 years of Non-Current Receivables data on file, last reported at $658000.0 in Q1 2026.
- Quarterly Non-Current Receivables fell 29.78% year-over-year to $658000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $658000.0 (down 29.78% YoY) and the FY2025 annual result came in at $731000.0, down 36.98% from the prior year.
- Non-Current Receivables retreated to $658000.0 in Q1 2026 per LNSR's latest filing, from $731000.0 in the prior quarter.
- Across five years, Non-Current Receivables topped out at $1.3 million in Q4 2023 and bottomed at $29000.0 in Q2 2022.
- The 5-year median for Non-Current Receivables is $896000.0 (2025), against an average of $829500.0.
- The widest annual swing landed in 2022, when Non-Current Receivables tumbled 89.45%; it then surged 4110.34% in 2023.
- Tracing LNSR's Non-Current Receivables over 5 years: stood at $442000.0 in 2022, then soared by 189.37% to $1.3 million in 2023, then dropped by 9.3% to $1.2 million in 2024, then sank by 36.98% to $731000.0 in 2025, then retreated by 9.99% to $658000.0 in 2026.
- Per Business Quant, the three latest LNSR Non-Current Receivables figures stand at $658000.0 (Q1 2026), $731000.0 (Q4 2025), and $806000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 257.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | 658,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 658,000.00 |
| Dec 31, 2025 | 731,000.00 |
| Sep 30, 2025 | 806,000.00 |
| Jun 30, 2025 | 855,000.00 |
| Mar 31, 2025 | 937,000.00 |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 952,000.00 |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 768,000.00 |
| Dec 31, 2022 | 442,000.00 |
| Jun 30, 2022 | 29,000.00 |
| Mar 31, 2022 | 62,000.00 |
| Dec 31, 2021 | 121,000.00 |
| Sep 30, 2021 | 190,000.00 |
| Jun 30, 2021 | 275,000.00 |
| Mar 31, 2021 | 364,000.00 |
| Dec 31, 2020 | 452,000.00 |
| Sep 30, 2020 | 538,000.00 |
| Dec 31, 2019 | 827,000.00 |